Advances in determining new treatments for hepatitis B infection by utilizing existing and novel biomarkers.

Lung-Yi MakRex Wan-Hin HuiKa-Shing CheungJames FungWai-Kay SetoMan-Fung Yuen

Published in: Expert opinion on drug discovery (2023)

Novel serum viral biomarkers and immunological markers are indispensable in the HBV functional cure program. These will likely become part of standard monitoring soon.

Keyphrases

hepatitis b virus
sars cov
quality improvement
liver failure